168 related articles for article (PubMed ID: 27659535)
1. Generation of affibody molecules specific for HPV16 E7 recognition.
Xue X; Wang B; Du W; Zhang C; Song Y; Cai Y; Cen D; Wang L; Xiong Y; Jiang P; Zhu S; Zhao KN; Zhang L
Oncotarget; 2016 Nov; 7(45):73995-74005. PubMed ID: 27659535
[TBL] [Abstract][Full Text] [Related]
2. Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer.
Zhu S; Zhu J; Song Y; Chen J; Wang L; Zhou M; Jiang P; Li W; Xue X; Zhao KN; Zhang L
Appl Microbiol Biotechnol; 2018 Sep; 102(17):7429-7439. PubMed ID: 29938318
[TBL] [Abstract][Full Text] [Related]
3. A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.
Wang L; Du W; Zhu S; Jiang P; Zhang L
Appl Microbiol Biotechnol; 2019 Apr; 103(7):3049-3059. PubMed ID: 30770966
[TBL] [Abstract][Full Text] [Related]
4. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
5. A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer.
Jiang P; Wang L; Hou B; Zhu J; Zhou M; Jiang J; Wang L; Chen S; Zhu S; Chen J; Zhang L
Theranostics; 2018; 8(13):3544-3558. PubMed ID: 30026865
[TBL] [Abstract][Full Text] [Related]
6. Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.
Zhu J; Kamara S; Wang Q; Guo Y; Li Q; Wang L; Chen J; Du Q; Du W; Chen S; Zhu S; Chen J; Chu M; Zhang L
Front Cell Dev Biol; 2021; 9():677867. PubMed ID: 34109181
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
[TBL] [Abstract][Full Text] [Related]
9. Nanobody against the E7 oncoprotein of human papillomavirus 16.
Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
11. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
12. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
13. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
Wick DA; Webb JR
Vaccine; 2011 Oct; 29(44):7857-66. PubMed ID: 21816200
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
15. Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo.
Tan X; Yang J; Jiang J; Wang W; Ren J; Li Q; Xie Z; Chen X; Zhang L; Li W
Eur J Pharm Sci; 2022 May; 172():106156. PubMed ID: 35245683
[TBL] [Abstract][Full Text] [Related]
16. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
17. Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.
Lin Z; Zhao Y; Li Q; Ci X; Ye X; Chen G; Tu Q; Feng W; Jiang P; Zhu S; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
Carcinogenesis; 2022 Jun; 43(5):479-493. PubMed ID: 35134836
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells.
Accardi L; Donà MG; Mileo AM; Paggi MG; Federico A; Torreri P; Petrucci TC; Accardi R; Pim D; Tommasino M; Banks L; Chirullo B; Giorgi C
BMC Cancer; 2011 Jan; 11():17. PubMed ID: 21241471
[TBL] [Abstract][Full Text] [Related]
19. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
